Zobrazeno 1 - 10
of 326
pro vyhledávání: '"Microparticle Enzyme Immunoassay"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Hepatology, Vol 1, Iss 4, Pp 179-182 (2002)
The most practical screening test for hepatitis C virus antibodies are second and third-generation enzyme immunoassays. We evaluated the usefulness of the third generation microparticle enzyme immunoassay (MEIA) in predicting HCV viraemia in anti-HCV
Externí odkaz:
https://doaj.org/article/70656aee01a34d3a9bbbacf5ec1b24a8
Publikováno v:
Upsala Journal of Medical Sciences
Background Although high-performance liquid chromatography (HPLC) is the method of choice for blood sirolimus determination, the microparticle enzyme immunoassay (MEIA) run on the IMx® analyser is widely used in therapeutic monitoring of this immuno
Publikováno v:
Thrombosis Research
Introduction Beriate® P was first introduced in Germany in 1990 as factor VIII (FVIII):C® HS Behring and subsequent product improvements yielded an albumin-free formulation with a specific activity of approximately 170 IU/mg protein. In 1992, the c
Autor:
Debra Sierka, Joan M. Korth-Bradley, Didier A. Mandelbrot, Daniel I. Levy, Michael A. Tortorici, David W. Holt, Sandi See Tai, Gary L. Horowitz
Publikováno v:
Clinical Transplantation. 28:243-251
Results of therapeutic monitoring of sirolimus blood concentrations are assay and laboratory dependent. This study compared performance over time of the IMx microparticle enzyme immunoassay (MEIA), Architect chemiluminescent microparticle immunoassay
Autor:
B Poppi, Valentina Ruggieri, Daria Brovia, Diego Pinetti, Daniela Gallesi, Carmela Nives Castellana, Stefania Pisa, Luigi Alberto Pini, Alfio Bertolini
Publikováno v:
Journal of Clinical Laboratory Analysis. 20:239-244
Sirolimus is a immunosuppressive agent for renal transplant recipients. Monitoring of whole blood sirolimus concentration is necessary in order to improve clinical outcomes. An increasing number of clinical laboratories (4–14% during 2005) are usin
Autor:
Aurélie Velay, Christine Prin-Mathieu, Evelyne Schvoerer, Hélène Jeulin, Sophie Lafontaine, Odette Agulles
Publikováno v:
Clinical Laboratory
Clinical Laboratory, Clinical Laboratory Publications, 2016, 62 (3), pp.275-84. ⟨10.7754/clin.lab.2015.150214⟩
Clinical Laboratory, Clinical Laboratory Publications, 2016, 62 (3), pp.275-84. ⟨10.7754/clin.lab.2015.150214⟩
The International Standard ISO 15189 based on the ISO 9001:2008 emphasizes specific requirements for quality and ability of medical laboratories. The accreditation of medical laboratories according to ISO 15189 includes the validation of biological m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972963212096cefdf49d6cd0b2bced82
https://hal.univ-lorraine.fr/hal-02014290
https://hal.univ-lorraine.fr/hal-02014290
Publikováno v:
Therapeutic Drug Monitoring, 34(2), 134-142. LIPPINCOTT WILLIAMS & WILKINS
Background: A bioalanytical method for the quantification of tacrolimus (TAC) and 3 metabolites, 13-O, 15-O, and 31-O-demethylated TAC (M-I, M-III, and M-II) in human whole blood using liquid chromatography, electrospray ionization, tandem mass spect
Autor:
Nafija Serdarevic
Publikováno v:
Journal of Health Sciences, Vol 1, Iss 3 (2011)
Introduction: The aim of this study was determination of troponin I at serum using Architect (Abbott) and AxSYM System (Abbott). Troponin is regulatory subunit of the troponin complex associate with actin filament within muscle cells and it is a mark
Publikováno v:
Farmacia Hospitalaria (English Edition). 35:256-259
Objective To assess the technique employed by the autoanalyser Architect® i1000 sr to determine digoxin in serum samples, compared with the assay developed for AsSYM® using microparticle enzyme immunoassay (Digoxin II). Method A prospective analysi